Security key
29384C108
Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)
CUSIP: 29384C108
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 24,517,008
- Total 13F value
- $386,369,092
- Share change
- -261,782
- SEC-reported price per share
- $15.76
- Number of holders
- 33
- Value change
- -$2,728,204
- Number of buys
- 16
- Number of sells
- 15
- Shares outstanding
- 39,267,778
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
33
Top holders
10
TRDA full security history
Ownership snapshot
Full 13F holder table
Entrada Therapeutics, Inc. SEC filings
Entrada Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
3/4/5
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
12%
MPM ASSET MANAGEMENT LLC
11%
5AM Venture Management, LLC
11%
PRICE T ROWE ASSOCIATES INC /MD/
6.2%
Redmile Group, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
Company
|
12%
|
$59,266,000
4,865,819 shares
|
— | 30 Jun 2022 |
| MPM ASSET MANAGEMENT LLC |
13F
Company
|
11%
|
$53,906,000
4,425,784 shares
|
— | 30 Jun 2022 |
| 5AM Venture Management, LLC |
13F
Company
|
11%
|
$53,694,000
4,408,379 shares
|
— | 30 Jun 2022 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
6.2%
|
$29,689,000
2,437,498 shares
|
— | 30 Jun 2022 |
| Redmile Group, LLC |
3/4/5
13F
10%+ Owner · Company
|
5%
from 13F
|
$31,251,176
1,954,420 shares
|
— | 02 Nov 2021 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
3.9%
|
$18,707,000
1,535,883 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
24,517,008
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
35
Q3 2022 holders
33
Holder diff
-2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|